	Capital Social Ordinario		Fecha
AbbVie	USD 1.77B	1.75B	2025-06
Acadia Pharmaceuticals	USD 169.18M	470K	2025-12
Akebia Therapeutics	USD 2K	0	2025-03
ALKERMES	USD 165.61M	503K	2025-12
Alnylam Pharmaceuticals	USD 132.38M	585K	2025-12
Amarin	USD 20.8M	28K	2025-09
Amgen	USD 539M	1000K	2025-12
Baxter International	USD 514.28M	168.72M	2025-12
Biogen	USD 146.7M	200K	2025-09
BioMarin Pharmaceutical	USD 192.3M	201K	2025-12
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Coherus Biosciences	USD 12K	0	2025-03
Eli Lilly	USD 946.83M	354.23M	2025-06
Fujifilm	JPY 1.21B	19K	2025-12
Gilead Sciences	USD 1.24B	1000K	2025-12
Ironwood Pharmaceuticals	USD 160K	0	2024-12
Merck	USD 2.49B	15.79M	2025-09
Myriad Genetics	USD 93.1M	0	2025-09
Pacira	USD 41.12M	1.85M	2025-12
Perrigo	USD 137.6M	0	2025-12
Pfizer	USD 5.69B	1000K	2025-09
PTC Therapeutics	USD 81.47M	1.54M	2025-12
Regeneron Pharmaceuticals	USD 105.3M	1.1M	2025-09
Sarepta Therapeutics	USD 104.96M	196K	2025-12
Teva Pharmaceutical Industries	USD 1.15B	0	2025-12
Vertex Pharmaceuticals	USD 254M	0	2025-12
Xencor	USD 71.87M	529K	2025-12
Zoetis	USD 424.93M	16.54M	2025-12

Coherus Biosciences Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.